Atlantic Private Wealth’s Avidity Biosciences RNAM Stock Holding History

Atlantic Private Wealth’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5	Closed	-$361	–	386
2025 Q4	$361	Buy	+5	New	+$323	﹤0.01%	356

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Atlantic Private Wealth's RNAM Position: Q1 2026 in Review

Atlantic Private Wealth sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 5 shares — an estimated $361 sold.

Atlantic Private Wealth first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $361 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Atlantic Private Wealth reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Atlantic Private Wealth sold 5 Avidity Biosciences shares in Q1 2026, an estimated $361.
Atlantic Private Wealth first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Atlantic Private Wealth's Avidity Biosciences position peaked at $361 in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Atlantic Private Wealth's 13F filing for Q1 2026, filed 8 May 2026.